All Outputs (123)

The media and communication industries: flexible friends or foes? (2007)
Presentation / Conference Contribution
MARCELLA, R., ILLINGWORTH, L. and BAXTER, G. 2007. The media and communication industries: flexible friends or foes? Presented at the 3rd Joint conference of the Media, Communication and Cultural Studies Association (MeCCSA) and Association of Media Practice Educators (AMPE), 10-12 January 2007, Coventry, UK.

This conference paper presented the key results of the research project 'Women in the Scottish Creative Industries', funded by the European Social Fund. This research explored the equality policy and practice in companies in the Scottish creative sec... Read More about The media and communication industries: flexible friends or foes?.

Poverty: an international glossary. (2007)
Book
SPICKER, P., LEGUIZAMÓN, S.A. and GORDON, D. (eds.) 2007. Poverty: an international glossary. 2nd edition. CROP international studies in poverty research. London: Zed Books [online]. Available from: https://www.crop.org/viewfile.aspx?id=238

This second edition of this highly-successful glossary provides an exhaustive and authoritative guide to over 200 technical terms used in contemporary scholarly research on poverty. It seeks to make researchers, students and policy makers aware of th... Read More about Poverty: an international glossary..

The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1α(βS*,δS*),2α,6α,8β- (R*),8aα]]-1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8- (2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester), reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice. (2007)
Journal Article
DEVER, G., SPICKETT, C.M., KENNEDY, S., RUSH, C., TENNANT, G., MONOPOLI, A. and WAINWRIGHT, C.L. 2007. The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1α(βS*,δS*),2α,6α,8β- (R*),8aα]]-1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8- (2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester), reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice. Journal of pharmacology and experimental therapeutics [online], 320(1), pages 419-426. Available from: https://doi.org/10.1124/jpet.106.109298

Statins possess anti-inflammatory effects that may contribute to their ability to slow atherogenesis, whereas nitric oxide (NO) also influences inflammatory cell adhesion. This study aimed to determine whether a novel NO-donating pravastatin derivati... Read More about The nitric oxide-donating pravastatin derivative, NCX 6550 [(1S-[1α(βS*,δS*),2α,6α,8β- (R*),8aα]]-1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8- (2-methyl-1-oxobutoxy)-1-naphtalene-heptanoic acid 4-(nitrooxy)butyl ester), reduces splenocyte adhesion and reactive oxygen species generation in normal and atherosclerotic mice..